TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023)
TherapeuticsMD's (TXMD) quarterly Other Non Operating Income came in at $359000.0 in Q3 2023, up 420.54% on a YoY basis from $68967.4 in Q3 2022, and up 248.54% quarter-over-quarter from $103000.0 in Q2 2023.
Analysis
TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023) Analysis & Trends
TherapeuticsMD (TXMD) has reported Other Non Operating Income for 12 consecutive years, with $359000.0 the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Other Non Operating Income rose 420.54% year-over-year to $359000.0; the trailing twelve-month figure through Sep 2023 stood at $880000.0 (up 110.33% YoY), and the FY2022 full-year result was -$117000.0, down 143.01% from the prior year.
- Other Non Operating Income advanced to $359000.0 in Q3 2023 per TXMD's latest filing, from $103000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $703662.0 in Q3 2019 and bottomed at -$10.1 million in Q2 2019.
- Historically, Other Non Operating Income has averaged -$815051.8 across 5 years, with a median of $89000.0 in 2020.
- The sharpest annual moves came in 2020 and 2022: Other Non Operating Income surged 35969.57% in 2020, then tumbled 6985.25% in 2022.
- Over 5 years, Other Non Operating Income stood at -$368.0 in 2019, then soared by 35969.57% to $132000.0 in 2020, then slumped by 93.94% to $8000.0 in 2021, then soared by 37.5% to $11000.0 in 2022, then jumped by 3163.64% to $359000.0 in 2023.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $359000.0, $103000.0, and $407000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 359,000.00 |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | 407,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -8.40 Mn |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 123,000.00 |
| Mar 31, 2021 | 122,000.00 |
| Dec 31, 2020 | 132,000.00 |
| Sep 30, 2020 | 42,000.00 |
| Jun 30, 2020 | 89,000.00 |
| Mar 31, 2020 | 335,000.00 |
| Dec 31, 2019 | -368.00 |
| Sep 30, 2019 | 703,662.00 |
| Jun 30, 2019 | -10.10 Mn |
| Mar 31, 2019 | 688,721.00 |
| Dec 31, 2018 | 823,027.00 |